Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 406

recruiting
3 972
countries
28
conditions
2 123

10 535 trials match your criteria

Breast cancer

Not yet recruiting

Study of tamoxifen loading dose and Ki67 response in breast cancer patients before surgery (ENDO-67)

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen

Study of Pozelimab and Cemdisiran in Adults with Paroxysmal Nocturnal Hemoglobinuria Not Responding Well to Current C5 Inhibitor Treatment

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran

Appendicitis

Not yet recruiting

Study comparing amoxicillin/clavulanic acid treatment versus surgery for children with uncomplicated appendicitis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Amoxicillin

Deafness

Not yet recruiting

Study of Aspirin and Folic Acid Treatment for Patients with Sudden Sensorineural Hearing Loss

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid

Cognitive disorder

Not yet recruiting

Study of Citicoline to Prevent Cognitive Decline After Delirium in Older Adults with Hip Fracture

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Citicoline

Multiple sclerosis

Not yet recruiting

Study of Tenofovir Alafenamide as Add-on Treatment to Anti-CD20 Therapy in Multiple Sclerosis Patients to Reduce Neuronal Damage

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Tenofovir Alafenamide

Coronary artery disease+2

Not yet recruiting

Study of ceftriaxone and amoxicillin treatment in patients with acute coronary syndrome, non-ST-elevation myocardial infarction, or ST-elevation myocardial infarction

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone

Colorectal cancer

Not yet recruiting

Study of ipilimumab, nivolumab, temozolomide and capecitabine in patients with chemotherapy-resistant metastatic colorectal cancer with specific genetic markers

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine

Dermatitis atopic

Not yet recruiting

Study of Lebrikizumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis to Understand How the Medicine Works

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab

Depression

Not yet recruiting

Study of prucalopride and escitalopram combination to improve treatment response in patients with major depressive disorder

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Escitalopram

Non-small cell lung cancer

Not yet recruiting

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Study of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Amphotericin B
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.